Skip to main content
Hexarelin
Ghrelin Receptor Agonist Research
Recovery Systems
Recovery Systems
New

Hexarelin

Hexarelin is a synthetic hexapeptide of 6 amino acids (His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH2) synthesised as a ghrelin-receptor agonist, studied in GH-axis and cardiac recovery research for its role in agonising the ghrelin (GHSR-1a) and cardiac CD36 receptors.

Quality information

A potent GHRP studied for robust pulsatile GH release — investigated in sleep depth, overnight recovery, and short-cycle performance protocols.

For Research Use Only — Not for Human Consumption.

Sold strictly for in vitro laboratory research purposes.

Listed under the WADA 2026 Prohibited List.

Not for use by competitive athletes in sanctioned sports.

In stock now

Hexarelin is out of stock. These are in stock.

Different compounds, matched on shared research goal and comparable cost per mg. They are not substitutes for one another — read the research on each page before you order.

Why it is not stocked

All four Hexarelin sizes are out of stock. The pharmacology, research notes and FAQ on this page stay published as the compound reference.

  1. IpamorelinSelective Growth Hormone ResearchSame goal · €4.40 / mgfrom €44
  2. CJC-1295 No DAC + IpamorelinDual-Pathway Growth Hormone ResearchSame goal · €7.50 / mgfrom €75
  3. CJC-1295 No DACPulsatile Growth Hormone ResearchSame goal · €4.00 / mgfrom €40
Browse the full shop
Size
€30€365 mg · Incl. VAT · €6.00 / mg
Out of stock
Email me when this batch returns

Single email when this batch is back. No marketing list, no follow-ups.

Storage
Store 2–8 °C. Use reconstituted vial within 14 days.
What this peptide is for

Ghrelin Receptor Agonist Research.

Hexarelin (CAS 140703-51-1) is a synthetic hexapeptide ghrelin-receptor agonist, structurally related to GHRP-6, with strong GH-releasing potency. Research has examined its role in pituitary GH secretion, cardiac-tissue signalling, and short-cycle anabolic response. Formula C47H58N12O6, MW 887.04 g/mol.

Linked research
  • — Imbimbo et al. — Hexarelin GH-release potency in healthy adults
  • — Locatelli et al. — Hexarelin signalling in cardiac and pituitary tissue

Research context only. Not medical advice. Not for human or veterinary use.

Specification
  • 5 mg lyophilised powder per vial
  • Reconstitute with bacteriostatic water before use
  • Store lyophilised at 2–8 °C, keep from light
  • Once reconstituted, refrigerate and use within 14 days
What arrives in the box
  • One vial in the selected size
  • Tamper-evident cap with batch-coded label
  • Storage card with reconstitution guidance
Pharmacology

What the research reports about this molecule.

Classic parameters from peer-reviewed literature. Not human dosing guidance — read alongside the PubMed references on /learn.

Sequence
Hexapeptide (6 amino acids): His-D-2Me-Trp-Ala-Trp-D-Phe-Lys-NH2
Molecular weight
887 Da
Mechanism
Ghrelin (GHSR-1a) + cardiac CD36 receptor agonist
Research domain
GH-axis, cardiac recovery
Reconstitution
Bacteriostatic water, USP
Storage
Sealed: 2–8 °C, away from light; reconstituted: 2–8 °C, use within 14 days
Handling & storage

From arrival to storage.

Laboratory handling notes for this compound. Peptyds products are supplied for research use only, not for human or veterinary use, so we give no dosing or administration guidance.

  1. 1

    Store the sealed vial at 2–8 °C, away from light

  2. 2

    Reconstitute with 2 mL bacteriostatic water — swirl gently

  3. 3

    Label the vial with its batch number and reconstitution date

  4. 4

    Refrigerate reconstituted vial; use within 14 days

Handling guide

Read the reconstitution guide

Reconstitution and storage for laboratory handling, step by step.

Reconstitution calculator

Research use only

Syringe

Peptide in vial

Bacteriostatic water

Concentration2.5 mg/mL

Target dose

Pull syringe to

10

units · 0.1 mL

010203040506070809010010

Concentration

2.5

mg/mL

Doses per vial

20

doses

U-50 5 · U-40 4 units

For laboratory research calculation only. Not medical or dosing advice, and not for human or veterinary use.

Others researching Recovery also compare

Questions, answered plainly

Everything worth asking before you order.

Shipping, storage, quality, and when to speak to a clinician — without the runaround.

Where can I find product information?

Product pages contain product details and research information. Contact us if you have a question about an item.

Should I speak to a clinician before using a peptide?

We recommend it — especially if you are pregnant, nursing, managing a medical condition, or combining peptides with prescribed medication. Our product pages are educational. They are not medical advice and they do not replace a conversation with a qualified practitioner.

When will my order ship and arrive?

Dispatch timing can vary. We send tracking after the parcel is dispatched.

Are research peptides banned by WADA?

Several research peptides we list — including BPC-157, TB-500, GHRPs, and IGF-1 LR3 — are listed on the WADA Prohibited List under classes S0 (unapproved substances) and S2 (peptide hormones and growth factors). They are prohibited at all times, in and out of competition.

How do I reconstitute a lyophilised peptide vial?

Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.

How much bacteriostatic water should I add to my peptide vial?

The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.

How long does a reconstituted peptide stay stable in the fridge?

Most lyophilised peptides reconstituted with bacteriostatic water remain stable for 28–30 days at 2–8 °C, protected from light. A handful of short, fragile sequences — Epithalon among them — drop to roughly 14 days. Never freeze a reconstituted vial.

What side effects are most commonly reported across peptide research?

Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue. GLP-1 and dual-agonist class peptides add dose-dependent gastrointestinal effects.

Who should not use peptides?

Peptides are not appropriate for anyone who is pregnant, nursing, planning conception, under 18, managing active cancer, or on immunosuppressants — and competitive athletes governed by WADA must avoid every peptide on the prohibited list. Anyone with a personal or family history of melanoma should specifically avoid melanocortin-receptor agonists.